Nanomedicine for the prevention, treatment and imaging of atherosclerosis.

Nanomedicine for the prevention, treatment and imaging of atherosclerosis.

Taispeáin leaganacha eile (2)

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in developed countries, with an increasing prevalence due to an aging population. The pathology underpinning CVD is atherosclerosis, a chronic inflammatory state involving the arterial wall. Accumulation of low density lipo...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Psarros, C, Lee, R, Margaritis, M, Antoniades, C
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2012

Míreanna comhchosúla

Nanomedicine for the prevention, treatment and imaging of atherosclerosis
de réir: Psarros, C, et al.
Foilsithe / Cruthaithe: (2012)

Nanomedicine for the prevention, treatment and imaging of atherosclerosis.
de réir: Psarros, C, et al.
Foilsithe / Cruthaithe: (2012)

Nanomedicine for Diagnosis and Treatment of Atherosclerosis
de réir: Jingyun Cheng, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Construction of dual nanomedicines for the imaging and alleviation of atherosclerosis
de réir: Shuihua Zhang, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Nanomedicine-based drug delivery strategies for the treatment of atherosclerosis
de réir: Yongfang Lin, et al.
Foilsithe / Cruthaithe: (2024-06-01)

The role of adiponectin at different stages of atherosclerosis in heart failure: associations with myocardial redox state
de réir: Antonopoulos, A, et al.
Foilsithe / Cruthaithe: (2010)

Nanoparticles: a promising therapeutic approach in atherosclerosis.
de réir: Antoniades, C, et al.
Foilsithe / Cruthaithe: (2010)

Biomimetic nanomedicines for precise atherosclerosis theranostics
de réir: Ying Tao, et al.
Foilsithe / Cruthaithe: (2023-11-01)

Editorial: Advances on targeted nanomedicines for atherosclerosis
de réir: Qinggong Han, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis
de réir: Ping Ping Hu, et al.
Foilsithe / Cruthaithe: (2022-09-01)

Novel therapeutic strategies targeting vascular redox in human atherosclerosis.
de réir: Antonopoulos, A, et al.
Foilsithe / Cruthaithe: (2009)

Advanced targeted nanomedicines for vulnerable atherosclerosis plaque imaging and their potential clinical implications
de réir: Xue Li, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Statin treatment improves vascular redox state through a tetrahydrobiopterin-mediated re-coupling of endothelial nitric oxide synthase, in human atherosclerosis
de réir: Antoniades, C, et al.
Foilsithe / Cruthaithe: (2011)

Precision nanomedicine in atherosclerosis therapy: how far are we from reality?
de réir: Yee Shan Wong, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Multifunctional phototheranostic nanomedicine for cancer imaging and treatment
de réir: D. Gao, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Interrelationships between vascular superoxide and adiponectin biosynthesis in perivascular adipose tissue in human atherosclerosis
de réir: Bakogiannis, C, et al.
Foilsithe / Cruthaithe: (2010)

Shedding new light on atherosclerosis therapeutics: Nanomedicines targeting atherosclerotic immune microenvironment
de réir: Zhiyue Wang, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Nanomedicine for renal cell carcinoma: imaging, treatment and beyond
de réir: Ruolin Wu, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Adiponectin as a regulator of vascular redox state in human atherosclerosis
de réir: Margaritis, M
Foilsithe / Cruthaithe: (2016)

Macrophage-targeting Antisenescence nanomedicine enables in-Situ NO induction for Gaseous and antioxidative atherosclerosis intervention
de réir: Yuanyuan Peng, et al.
Foilsithe / Cruthaithe: (2025-06-01)

L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?
de réir: Siasos, G, et al.
Foilsithe / Cruthaithe: (2007)

A novel cross-talk between perivascular adipose tissue and the arterial wall controls redox state in human atherosclerosis
de réir: Margaritis, M, et al.
Foilsithe / Cruthaithe: (2013)

A NOVEL CROSS-TALK BETWEEN PERIVASCULAR ADIPOSE TISSUE AND THE ARTERIAL WALL CONTROLS REDOX STATE IN HUMAN ATHEROSCLEROSIS
de réir: Margaritis, M, et al.
Foilsithe / Cruthaithe: (2013)

Macrophage membrane-functionalized manganese dioxide nanomedicine for synergistic treatment of atherosclerosis by mitigating inflammatory storms and promoting cholesterol efflux
de réir: Sijin Chen, et al.
Foilsithe / Cruthaithe: (2024-10-01)

Insulin-induced vascular redox dysregulation in human atherosclerosis is ameliorated by dipeptidyl peptidase 4 inhibition
de réir: Akoumianakis, I, et al.
Foilsithe / Cruthaithe: (2020)

Insulin Treatment Induces Oxidative Stress in the Vascular Wall of Patients With Atherosclerosis Independently of Diabetes or Systemic Insulin Resistance: The Protective Role of DPP-IV Inhibition
de réir: Akoumianakis, I, et al.
Foilsithe / Cruthaithe: (2018)

An immunoregulator nanomedicine approach for the treatment of tuberculosis
de réir: Luona Yang, et al.
Foilsithe / Cruthaithe: (2023-05-01)

Challenges to Safe Nanomedicine Treatment
de réir: Chunhua Yang, et al.
Foilsithe / Cruthaithe: (2023-03-01)

Biomarkers of premature atherosclerosis.
de réir: Kampoli, A, et al.
Foilsithe / Cruthaithe: (2009)

Nanomedicine: Engineering of a tri-imageable nanoparticle for diagnostics
de réir: Bumb, A, et al.
Foilsithe / Cruthaithe: (2009)

Prevention and Regression of Atherosclerosis: Emerging Treatments
de réir: Aliosvi Rodríguez Rodríguez, et al.
Foilsithe / Cruthaithe: (2014-06-01)

Statins in coronary artery bypass grafting surgery: lipid lowering and beyond.
de réir: Margaritis, M, et al.
Foilsithe / Cruthaithe: (2012)

The role of perivascular fat in the diagnosis and prognosis of atherosclerosis
de réir: Polkinghorne, M, et al.
Foilsithe / Cruthaithe: (2022)

Homocysteine lowering: any use in atherosclerosis?
de réir: Antoniades, C, et al.
Foilsithe / Cruthaithe: (2007)

Atorvastatin rapidly reduces myocardial superoxide and peroxynitrite generation in human atherosclerosis, by suppressing NADPH-oxidase activity independently of LDL lowering
de réir: Antoniades, C, et al.
Foilsithe / Cruthaithe: (2011)

Nanomedicine Explored at Molecular Imaging Summit
de réir: Julie L. Sutcliffe PhD
Foilsithe / Cruthaithe: (2011-01-01)

The Role of Optical Imaging in Translational Nanomedicine
de réir: Evelien Hesemans, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Advances in nanomedicines for lymphatic imaging and therapy
de réir: Pan He, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Nanomedicine for Imaging and Therapy of Pancreatic Adenocarcinoma
de réir: Giulia Brachi, et al.
Foilsithe / Cruthaithe: (2019-11-01)

Perivascular adipose tissue and coronary atherosclerosis
de réir: Mancio, J, et al.
Foilsithe / Cruthaithe: (2018)